Evaluation of a large-scale aptamer proteomics platform among patients with kidney failure on dialysis.
<h4>Background</h4>Patients with kidney failure suffer high mortality, and we currently lack markers for risk stratification for these patients. We carried out a quality control study of a modified aptamer assay (SomaScan v.4.0) that measures ~ 5000 proteins, in preparation for a larger...
Main Authors: | Yue Ren, Peifeng Ruan, Mark Segal, Mirela Dobre, Jeffrey R Schelling, Upasana Banerjee, Tariq Shafi, Peter Ganz, Ruth F Dubin, CRIC Study Investigators |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0293945 |
Similar Items
-
Evaluation of a large-scale aptamer proteomics platform among patients with kidney failure on dialysis
by: Yue Ren, et al.
Published: (2023-01-01) -
Validation of a Novel Modified Aptamer-Based Array Proteomic Platform in Patients with End-Stage Renal Disease
by: Zhongji Han, et al.
Published: (2018-10-01) -
Proteomics of CKD progression in the chronic renal insufficiency cohort
by: Ruth F. Dubin, et al.
Published: (2023-10-01) -
Proteomic Research in Peritoneal Dialysis
by: Mario Bonomini, et al.
Published: (2020-07-01) -
Agreement of aptamer proteomics with standard methods for measuring venous thrombosis biomarkers
by: Tariq Faquih, et al.
Published: (2021-05-01)